The FABP2 gene polymorphism in cerebrovascular disease

Acta Neurologica Scandinavica

Volumn 110, Issue 6, 2004, Pages 355-360

  Wanby, P ^a   Palmquist, P ^a   Ryden I ^a   Brattstrom L ^a   Carlsson, Martin ^a  

^a KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

FABP2; Genetics; Polymorphism; Stroke

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DYSLIPIDEMIA; EMBOLISM; FABP2 GENE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FATTY ACID-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 8844256586     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2004.00335.x     Document Type: Article

References (28)

1. JOUSILAHTI P, RASTENYTE D, TUOMILEHTO J, SARTI C, VARTIAINEN E. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke 1997;28:1361-6.
2. BRASS LM, ISAACSOHN JL, MERIKANGAS KR, ROBINETTE CD. A study of twins and stroke. Stroke 1992;23:221-3.
3. BRASS LM, SHAKER LA. Family history in patients with transient ischemic attacks. Stroke 1992;22:837-41.
4. ALBERTS MJ. Stroke genetics update. Stroke 2003;34: 342-4.
5. ROSAND J, ALTSHULER D. Human genome sequence variation and the search for genes influencing stroke. Stroke 2003;34:2512-6.
6. ZHANG F, LÜCKE C, BAIER LJ, SACCHETTINI JC, HAMILTON JA. Solution structure of human intestinal fatty acid binding protein: implications for ligand entry and exit. J Biomol NMR 1997;9:213-28.
7. COHN SM, SIMON TC, ROTH KA, BIRKENMEIER EH, GORDON JI. Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal -colonic and crypt-villus axis of the gut epithelium. J Cell Biol 1992;119:27-44.
8. BAIER LJ, SACCHETTINI JC, KNOWLER WC et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995;95:1281-7.
9. BAIER LJ, BOGARDUS C, SACCHETTINI JC. A polymorphism in the human intestinal fatty acid-binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996;271:10892-6.
10. HEGELE RA. A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components. Clin Biochem 1998;31:609-612.
11. TAHVANAINEN E, MOLIN M, VAINIO S et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000;152:317-25.
12. CARLSSON M, ORHO-MELANDER M, HEDENBRO J, ALMGREN P, GROOP LC. The T 54 allele of the fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metab 2000;85:2801-4.
13. HEGELE RA, HARRIS SB, HANLEY AJG, SADIKIAN S, CONNELLY PW, ZINMAN B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 1996;81:4334-7.
14. ÅGREN JJ, VALVE R, VIDGREN H, LAAKSO M, UUSITUPA M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 1998;18:1606-10.
15. PRATELY RE, BAIER L, PAN DA et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000;41:2002-8.
16. VIDGREN HM, SIPILÄINEN RH, HEIKKINEN S, LAAKSO M, UUSITUPA MI. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 1997;27:405-8.
17. ERKKILÄ AT, LINDI V, LEHTO S, PYÖRÄLÄ K, LAAKSO M, UUSITUPA MI. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. Nutr Metab Cardiovasc Dis 2002;12:53-59.
18. RYU JE, HOWARD G, CRAVEN TE, BOND G, HAGAMAN AP, CROUSE JR III. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992;23: 823-8.
19. O'LEARY DH, POLAK JF, KRONMAL RA et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992;23:1752-60.
20. GALLUZI JR, CUPPLES LA, OTVOS JD, WILSON PW, SCHAEFER EJ, ORDOVAS JM. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham offspring study. Atherosclerosis 2001;159:417-24.
21. AHO K, HARMSEN P, HATANO S, MARQUARDSEN J, SMIRNOV VE, STRASSER T. Cerebrovascular disease in the community: results of a WHO collaboration study. Bull World Health Organ 1980;58:113-30.
22. JEPPSSON JO, JERNTORP P, SUNDKVIST G, ENGLUND H, NYLUND V. Measurement of hemoglobin Alc by a new liquid-chromatography assay; methodology, clinical utility, and relation to tolerance evaluated. Clin Chem 1986;32: 1867-72.
23. KOUDSTAAL PJ, GIJN J, LODDER J et al. Transient ischemic attacks with and without a relevant infarct on computed tomographic scans cannot be distinguished clinically. Arch Neurol 1991;48:916-20.
24. RULAND S, GORELICK PB. Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor? Current Atherosclerosis Reports 2003;5:38-43.
25. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
26. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomized placebo-controlled trial. Lancet 2002;360:7-22.
27. HACHINSKI V, GRAAGNINO C, BEAUDRY M et al. Lipids and stroke; a paradox resolved. Arch Neurol 1996;53:303-8.
28. KHAW KT. Epidemiology of stroke. J Neurol Neurosurg Psychiatry 1996;61:333-8.